Lunit collabs with AstraZeneca, secures major deal in France
Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims to accelerate the time-consuming process of genomic testing as part of NSCLC identification and diagnosis by leveraging Lunit's AI. The latter's...
AI biotech company Owkin announced a partnership with pharma giant AstraZeneca to develop an AI-powered tool designed to prescreen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.
According to Owkin, BRCA testing, which identifies mutations in the BRCA1 and BRCA2 genes, plays an important role in deciding a person's risk for developing certain cancers,...
Pharma companies are seeing the value of digital health, and are creating departments focused on developing, scaling and investing in platforms that use technology to enhance life sciences R&D, better assist providers and engage with patients.
Sonny Shergill, vice president of commercial digital health at AstraZeneca, sat down with MobiHealthNews to discuss the evolution of its strategy...
Oncology-focused digital therapeutics company Mika Health announced a partnership with pharma companies AstraZeneca and Daiichi Sankyo for an initiative dubbed "UNITE" to provide digital therapeutics to women undergoing breast cancer treatments.
Mika Health's app gives cancer patients access to psychological support to reduce disease-related anxiety, depression and stress. Patients can track...
Absci, a startup focused on developing generative AI antibody discovery technology, announced a potential $247 million partnership with pharma giant AstraZeneca to focus on expediting the discovery of novel cancer treatments with the help of genAI technology.
The project will leverage Absci's Integrated Drug Creation platform – which combines scalable wet lab technologies with AI, and facilitates...
Pharmaceutical giant AstraZeneca announced the launch of Evinova, a health technology business focused on bringing digital health solutions already in use globally by the pharma company to clinical research organizations (CROs), trial sponsors and care teams, and patients.
The new company will use established digital technology solutions to streamline clinical trial design and delivery in order...
Health technology company PicnicHealth announced it is moving into the oncology space and teaming up with AstraZeneca to build a registry to generate real-world data on breast cancer.
The company says it will work with people living with cancer to collect and structure their medical records data to advance oncology research using robust datasets.
Additionally, the California-based company...
Indonesian digital pharmacy Lifepack scores $7M in Series A funding
Lifepack, a digital pharmacy in Indonesia, has raised $7 million in a Series A funding round led by Golden Gate Ventures.
Launched in 2020, the mobile health platform offers quality and cheap medicines, including over-the-counter drugs, general supplements, and medication for chronic illnesses. Available on Android and iOS...
Digital chronic disease management platform Health2Sync has signed a memorandum of understanding with pharmaceutical firm AstraZeneca to launch a digital patient management programme for patients with chronic kidney disease.
The digital programme seeks to promote the early diagnosis of CKD and optimise everyday CKD care using Health2Sync's patient management platform.
According to a media release...
Artificial intelligence could potentially disrupt nearly every industry. Pharma giants have continued to take note. From AI in drug discovery to digital therapeutics, big name life science companies have invested time and money into the space.
However, big tech's move fast and break things mentality doesn't always align with pharma's regulated model. Today a number of accelerators and labs are...
![[Left] Ed Deng, co-founder and CEO, Health2Sync; and [Right] Claudio Longo, President, AstraZeneca Taiwan](https://www.mobihealthnews.com/sites/default/files/styles/230x130/public/%28Left%29%20Ed%20Deng%2C%20Co-founder%20and%20CEO%20of%20Health2Sync%20and%20%28Right%29%20Claudio%20Longo%2C%20President%20of%20AstraZeneca%20Taiwan.jpg?itok=O1YqUgdy)
